Bovée JVMG - Search Results

1

Cellular Radiosensitivity of Soft Tissue Sarcoma.

Haas RL, Floot BGJ, Scholten AN, van der Graaf WTA, van Houdt W, Schrage Y, van de Ven M, Bovée JVMG, van Coevorden F, Vens C. Haas RL, et al. Among authors: bovee jvmg. Radiat Res. 2021 Jul 1;196(1):23-30. doi: 10.1667/RADE-20-00226.1. Radiat Res. 2021. PMID: 33914890

2

Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.

Rozeman LB, Szuhai K, Schrage YM, Rosenberg C, Tanke HJ, Taminiau AH, Cleton-Jansen AM, Bovée JV, Hogendoorn PC. Rozeman LB, et al. Cancer. 2006 Jul 15;107(2):380-8. doi: 10.1002/cncr.22001. Cancer. 2006. PMID: 16779802 Free article.

3

Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition.

Willems SM, Schrage YM, Baelde JJ, Briaire-de Bruijn I, Mohseny A, Sciot R, Bovée JV, Hogendoorn PC. Willems SM, et al. Histopathology. 2008 Mar;52(4):465-74. doi: 10.1111/j.1365-2559.2008.02967.x. Histopathology. 2008. PMID: 18315599

4

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.

Schrage YM, Lam S, Jochemsen AG, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, Bovée JV. Schrage YM, et al. J Cell Mol Med. 2009 Sep;13(9A):2843-52. doi: 10.1111/j.1582-4934.2008.00406.x. Epub 2008 Jun 27. J Cell Mol Med. 2009. PMID: 18624751 Free PMC article.

5

Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.

Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovée JV, Hogendoorn PC; EuroBoNeT consortium. Eefting D, et al. Am J Surg Pathol. 2009 Jan;33(1):50-7. doi: 10.1097/PAS.0b013e31817eec2b. Am J Surg Pathol. 2009. PMID: 18852676

6

Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.

Schrage YM, Hameetman L, Szuhai K, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, Bovée JV. Schrage YM, et al. Am J Pathol. 2009 Mar;174(3):979-88. doi: 10.2353/ajpath.2009.080623. Epub 2009 Jan 29. Am J Pathol. 2009. PMID: 19179614 Free PMC article.

7

Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment.

Schrage YM, Briaire-de Bruijn IH, de Miranda NF, van Oosterwijk J, Taminiau AH, van Wezel T, Hogendoorn PC, Bovée JV. Schrage YM, et al. Cancer Res. 2009 Aug 1;69(15):6216-22. doi: 10.1158/0008-5472.CAN-08-4801. Epub 2009 Jul 14. Cancer Res. 2009. PMID: 19602594

8

Metastatic potential of an aneurysmal bone cyst.

van de Luijtgaarden AC, Veth RP, Slootweg PJ, Wijers-Koster PM, Schultze Kool LJ, Bovee JV, van der Graaf WT. van de Luijtgaarden AC, et al. Virchows Arch. 2009 Nov;455(5):455-9. doi: 10.1007/s00428-009-0845-4. Epub 2009 Oct 17. Virchows Arch. 2009. PMID: 19838726 Free PMC article.

9

COX-2 expression in chondrosarcoma: a role for celecoxib treatment?

Schrage YM, Machado I, Meijer D, Briaire-de Bruijn I, van den Akker BE, Taminiau AH, Kalinski T, Llombart-Bosch A, Bovée JV. Schrage YM, et al. Eur J Cancer. 2010 Feb;46(3):616-24. doi: 10.1016/j.ejca.2009.11.002. Epub 2009 Dec 11. Eur J Cancer. 2010. PMID: 20004565

10

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.

Willems SM, Schrage YM, Bruijn IH, Szuhai K, Hogendoorn PC, Bovée JV. Willems SM, et al. Mol Cancer. 2010 Sep 23;9:257. doi: 10.1186/1476-4598-9-257. Mol Cancer. 2010. PMID: 20863376 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters